Rafferty Asset Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.84M | Buy |
265,928
+42,590
| +19% | +$776K | 0.02% | 407 |
|
|
2025
Q1 | $4.43M | Sell |
223,338
-289,790
| -56% | -$5.75M | 0.02% | 396 |
|
|
2024
Q4 | $8.8M | Buy |
513,128
+122,173
| +31% | +$2.1M | 0.03% | 306 |
|
|
2024
Q3 | $7.82M | Buy |
390,955
+111,078
| +40% | +$2.22M | 0.03% | 323 |
|
|
2024
Q2 | $3.13M | Sell |
279,877
-402,388
| -59% | -$4.5M | 0.01% | 518 |
|
|
2024
Q1 | $4.5M | Buy |
682,265
+137,916
| +25% | +$910K | 0.02% | 494 |
|
|
2023
Q4 | $2.46M | Sell |
544,349
-81,147
| -13% | -$367K | 0.01% | 624 |
|
|
2023
Q3 | $2.24M | Sell |
625,496
-92,632
| -13% | -$332K | 0.01% | 577 |
|
|
2023
Q2 | $2.65M | Sell |
718,128
-263,103
| -27% | -$971K | 0.01% | 567 |
|
|
2023
Q1 | $3.25M | Buy |
981,231
+191,833
| +24% | +$635K | 0.02% | 492 |
|
|
2022
Q4 | $3.06M | Buy |
789,398
+209,548
| +36% | +$813K | 0.03% | 478 |
|
|
2022
Q3 | $1.41M | Buy |
+579,850
| New | +$1.41M | 0.02% | 588 |
|